John Graham Cumming

Title: Innovations of John Graham Cumming

Introduction

John Graham Cumming is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as cytokine inhibitors. With a total of 11 patents to his name, Cumming's work has had a considerable impact on medical research and treatment options.

Latest Patents

Cumming's latest patents include innovative amide derivatives bearing a cyclopropylaminoacarbonyl substituent. These compounds are useful as cytokine inhibitors and are described by a specific formula where Qa is heteroaryl and is substituted with halogeno. In these compounds, R1 and R2 are each hydrogen, while Qb can be phenyl or heteroaryl, with the possibility of one or two substituents selected from hydroxy, halogeno, and (1-6C)alkyl. Additionally, these patents cover processes for their preparation, pharmaceutical compositions containing them, and their use in treating diseases or medical conditions mediated by cytokines.

Career Highlights

Throughout his career, John Graham Cumming has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Zeneca Limited. His experience in these organizations has allowed him to collaborate on various innovative projects and contribute to advancements in medical science.

Collaborations

Cumming has worked alongside notable colleagues such as Jeremy Nicholas Burrows and Dearg Sutherland Brown. These collaborations have further enriched his research and development efforts in the field of pharmaceuticals.

Conclusion

John Graham Cumming's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of treatments for medical conditions mediated by cytokines.